We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS: GENERIC PRODUCTS KEY TO LOWERING STATE Rx DRUG COSTS
CMS: GENERIC PRODUCTS KEY TO LOWERING STATE Rx DRUG COSTS
September 16, 2004
Aggressive substitution of generics in place of their brand counterparts can be a major source of savings for state Medicaid programs, according to a recent report issued by the Centers for Medicare & Medicaid Services (CMS).